As on Wednesday, BrightSpring Health Services Inc (NASDAQ: BTSG) got off with the flyer as it spiked 2.74% to $30.74, before settling in for the price of $29.92 at the close. Taking a more long-term approach, BTSG posted a 52-week range of $14.73-$30.35.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 60.10%. Meanwhile, its Annual Earning per share during the time was 60.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 72.87%. This publicly-traded company’s shares outstanding now amounts to $177.06 million, simultaneously with a float of $97.61 million. The organization now has a market capitalization sitting at $5.45 billion.
BrightSpring Health Services Inc (BTSG) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Health Information Services industry. BrightSpring Health Services Inc’s current insider ownership accounts for 44.90%, in contrast to 71.96% institutional ownership. Preceding that transaction, on Jun 24 ’25, Company’s 10% Owner sold 2,100,000 for 21.15, making the whole transaction’s value amount to 44,418,990. This particular insider is now the holder of 77,096,337 in total.
BrightSpring Health Services Inc (BTSG) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
BrightSpring Health Services Inc’s EPS increase for this current 12-month fiscal period is 72.87% and is forecasted to reach 1.25 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 38.77% through the next 5 years, which can be compared against the 60.10% growth it accomplished over the previous five years trading on the market.
BrightSpring Health Services Inc (NASDAQ: BTSG) Trading Performance Indicators
Let’s observe the current performance indicators for BrightSpring Health Services Inc (BTSG). It’s Quick Ratio in the last reported quarter now stands at 1.34. Alongside those numbers, its PE Ratio stands at $103.99, and its Beta score is 2.41. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.45. Similarly, its price to free cash flow for trailing twelve months is now 23.24.
In the same vein, BTSG’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.30, a figure that is expected to reach 0.28 in the next quarter, and analysts are predicting that it will be 1.25 at the market close of one year from today.
